|

RC148 plus Carboplatin and Paclitaxel Clinical Trials

1 actively recruiting trial

Also known as: RC148 plus Platinum-Based Chemotherapy

Pipeline

Phase 3: 1

Top Sponsors

  • RemeGen Co., Ltd.1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.